Prenetics Global Limited (NASDAQ:PRE) Sees Large Growth in Short Interest

Prenetics Global Limited (NASDAQ:PRE) was the target of a large growth in short interest during the month of October. As of October 31st, there was short interest totalling 38,700 shares, a growth of 19.8% from the October 15th total of 32,300 shares. Based on an average trading volume of 19,300 shares, the days-to-cover ratio is presently 2.0 days. Currently, 0.5% of the shares of the company are short sold.

Prenetics Global Stock Performance

NASDAQ:PRE traded down $0.31 during mid-day trading on Friday, hitting $4.50. 3,880 shares of the company traded hands, compared to its average volume of 5,355. Prenetics Global has a one year low of $2.85 and a one year high of $7.84. The stock’s fifty day moving average price is $4.53 and its 200-day moving average price is $5.27.

Prenetics Global (NASDAQ:PRE) last released its quarterly earnings data on Monday, October 7th. The company reported ($0.88) earnings per share for the quarter. The business had revenue of $5.94 million during the quarter. Prenetics Global had a negative return on equity of 15.70% and a negative net margin of 229.17%. Analysts forecast that Prenetics Global will post -3.32 EPS for the current year.

About Prenetics Global

Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment. It offers CircleDNA, a prevention arm that uses whole exome sequencing to offer comprehensive consumer DNA test. The company also, through its joint venture, Insighta, engages in pioneering multi-cancer early detection technologies.